Management of Health-Care-Associated Infections in the Oncology Patient

ONCOLOGY

Volumn 17, Issue 3, 2003, Pages 415-420

  John L , Guinan ^a   McGuckin, Maryanne ^b,c   Nowell, Peter C ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Rehabilitation Medicine ^*

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449779459     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. National Nosocomial Infection Surveillance Supplement Report: Data Summary, Oct 1986-April 199S. Am J Infect Control 26:522- 533, 1998.
2. Garner JS, Jarvis WR, Emori TG, et al: CDC definition of nosocomial infection. Am J Infect Control 16:128-140, 1988.
3. Kunin CM: Detection, Prevention and Management of Urinary Tract Infections, 3rd ed. Philadelphia, Lea &Febiger, 1979.
4. Guidelines for Prevention of Nosocomial Pneumonia. MMWR 46(RR-1);1-79, 1997.
5. Magee C, Rodeheaver GT, Golden GT, et al: Potentiation of wound infection by surgical drains. Am J Surg 131:547-559, 1976.
6. Maki DG: Infection due to infusion therapy, in Bennett JV, Brachman PS (eds): Hospital Infection, 3rd ed. Boston, Little, Brown, 1992.
7. Arnow PM, Quimosing EM, Beach M: Consequences of intravascular catheter sepsis. Clin Infect Dis 16:778-784, 1993.
8. Schimpff SC: Infections in the cancer patient. Diagnosis, prevention and treatments, in Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, 4th ed, pp 2666-2675. New York, Churchill Livingstone, 1995.
9. Schapira DV, Studnicki J, Bradham DD, et al: Concepts in emergency and critical care intensive care: Survival and expense of treating critically ill cancer patients. JAMA 269:783-786, 1993.
10. Velasco F, Thuler L, Martins CA, et al: Nosocomial infection in an oncology intensive care unit. Am J Infect Control 26:458-462, 1997.
11. Mangram AJ, Horan TC, Pearson ML, et al: Guideline for prevention of surgical' site infection, 1999. Infect Control Hosp Epidemiol 20:250-278, 1999.
12. Cruse PJ, Foord R: The epidemiology of wound infection: A 20-year prospective study of 62, 939 wounds. Surg Clin North Am 60:27-40, 1980.
13. Netherlands vs Belgium. Infect Control Hosp Epidemiol 157:574-578, 1994.
14. Culver D, Horan T, Baynes RP, et al and the National Nosocomial Infections Surveillance System: Surgical wound infection rates by wound class, operative procedure and patient risk index. Am J Med 91(suppl 3B):152-157, 1991.
15. Haley RW: Nosocomial infections in surgical patients: Developing valid measures of intrinsic patient risk. Am J Med 91(suppl 3B):145-151, 1991.
16. Barber GR, Miransky J, Brown AE, et al: Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 130:1042-1047, 1995.
17. Meuid MM, Denobis D, Meguid V, et al: Complication of abdominal operations for malignant disease. Am J Surg 156:341-345, 1988.
18. Velasco F, Thuler L, Martinis C, et al: Risk factors for infectious complications after abdominal surgery for malignant disease. Am J Infect Control 24:1-6, 1996.
19. Vilar-Compte D, Mohar A, Sandoval S, et al: Surgical site infections at the National Cancer Institute in Mexico. A case-control study. Am J Infect Control 28:14-20, 2000.
20. Dougherty SH, Simmons RL: The biology and practice of surgical drains. Part II. Curr ProblSurg 29:633-730, 1992.
21. Moro MI, Carried MP, Tozzi AE, et al: Risk factors for surgical wound infections in clean surgery: A multicenter study. Italian PRI- NOS Study Group. Ann Ital Chir 67:13-19, 1996.
22. Capital Health Annual Report: 1995-1996. Edmonton, Alberta, Canada Capital Health Authority, 1996.
23. Simon A, Fleischhack G, Hasan C, et al: Surveillence for nosocomial and central line- related infections among pediatric hematolo- gy-oncology patients. Infect Control Hosp Epidemiol 21:592-596, 2000.
24. Raad I, Abi-Said D, Carrasco CH, et al: The risk of infection associated with intra-arterial catheters for cancer chemotherapy. Infect Control Hosp Epidemiol 19:640-642, 1998.
25. Press OW, Ramsey PG, Larson EB, et al: Hickman catheters in patients with malignancies. Medicine 63:189-200, 1984.
26. Hickman RO, Buckner CD, Clift RA, et al: A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 48:871-875, 1979.
27. Rotstein C, Brock L, Roberts R: The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 16:451-458, 1995.
28. Ryder MA: Peripheral access options. Surg Oncol Clin N Am 4:395-427, 1995.
29. Raad 1, Davis S, Becker M, et al: Low infection rate and long durability of nontun- neled silastic catheters. A safe cost-effective alternative for long-term venous access. Arch Intern Med 153:1791-1796, 1993.
30. Noble WC: Skin microbiology: Coming of age-J Med Microbiol 17:1-12, 1984.
31. Maki DG, McCarmick RD, Uman SJ, et al: Septic endarteritis due to intra-arterial catheters for cancer chemotherapy. I. Evaluation of an outbreak. II. Risk factors, clinical features and management. Ill Guidelines for prevention. Cancer 14:1228-1240, 1979.
32. Mermel LA: New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 7:197-199, 2001.
33. Segura M, Alvarez-Lerma F, Tellado JM, et al: A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg 223:363-369, 1996.
34. Veenstra DL, Saint S, Sullivan SD: Cost- effectiveness of antiseptic-impregnated central venous catheters for prevention of catheter- related bloodstream infection. JAMA 282:554-560, 1999.
35. Darouiche RO, Raad II, Heard SO, et al: A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 340:1-8, 1999.
36. Raad I, Darouiche R, Dupuis J, et al: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infection. A randomized, double-blind trial. Ann Intern Med 127:267-274, 1997.
37. Sampath L, Tambe S, Modak S: Comparison of the efficacy of antiseptic and antibiotic catheters impregnated on both their luminal and outer surfaces (abstract), in Programs and of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1999.
38. Maki DG, Mermel LA, Kluger D, et al: The efficacy of a chlorhexidine-impregnated sponge (Biopatch™) for the prevention of intravascular catheter-related infection: A prospective, randomized, controlled, multicenter study, in Programs and of the 40th lnterscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 2000.
39. Gamer JS: Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 17:53-80, 1996.
40. Kuehnert MJ, Jernigan JA, Pullen AL, et al: Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol 20:660-663, 1999.
41. Hospital Infection Control Prevention Advisory Committee. MMWR 46:RR-1, 1994.
42. Rubio M, Palau L, Vivas JR, et al: Predominance of gram-positive microorganisms as a cause of septicimia in patients with hematological malignancies. Infect Control Hosp Epidemiol 15:101-104, 1994.
43. Penzak SR, Gubbins PO, Stratton SL, et al: Investigation of an outbreak of gram-negative bacteremia among hematology-oncology outpatients. Infect Control Hosp Epidemiol 21:597-599, 2000.
44. Thuler L, Velasco E, de Souza Martins C, et al: An outbreak of Bacillus species in a cancer hospital. Infect Control Hosp Epidemiol 19:856-858, 1998.
45. Velasco, F, Thuler L, Martins CA, et al: Risk index for prediction of surgical site infection after oncology operations. Am J Infect Control 26:217-223, 1998.
46. Spanik S, West D, Pichna P, et al: Inappropriate antibiotic therapy febrale cancer patients with bacteremia. Clin Perform Qual Health Care 6:109-113, 1998.
47. Bodey GP, Jadeja L, Elting L: Pseudomonas bacteremia: Retrospective analysis of 410 episodes. Arch hit Med 145:1621-1629, 1985.
48. Boyce JM, Pittet D: Guidelines for hand hygiene in health-care settings. Infect Control Hosp Epidemiol 231(supp S3-S40):2002.
49. McGuckin M, Waterman R, Porten L, et al: Patient education model for increasing handwashing compliance. Am J Infect Control 27:309-314, 1999.
50. McGuckin M, Waterman R, Storr IJ, et al: Evaluation of a patient-empowering hand hygiene programme in the UK. J Hosp Infect 48:222-227, 2001.
51. Shulkin DJ, Kinosian B, Glick H, et al: The economic impact of infections. An analysis of hospital costs and charges in surgical patients with cancer. Arch Surg 128:449-452, 1993.